Search

Search Constraints

You searched for: Author/Creator Simpson, E.L.

Search Results

3. A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. (8th November 2020)

5. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. (1st October 2017)

6. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. (5th September 2017)

7. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate‐to‐severe atopic dermatitis. (1st June 2020)

10. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (1st August 2020)